578 related articles for article (PubMed ID: 16464652)
1. Serum antibodies to enterohepatic Helicobacter spp. in patients with chronic liver diseases and in a population with high prevalence of H. pylori infection.
Vorobjova T; Nilsson I; Terjajev S; Granholm M; Lyyra M; Porkka T; Prükk T; Salupere R; Maaroos HI; Wadström T; Uibo R
Dig Liver Dis; 2006 Mar; 38(3):171-6. PubMed ID: 16464652
[TBL] [Abstract][Full Text] [Related]
2. Immunoblot analysis as an alternative method to diagnose enterohepatic Helicobacter infections.
Wadström T; Hau J; Nilsson I; Ljungh A
Helicobacter; 2009 Jun; 14(3):172-6. PubMed ID: 19702846
[TBL] [Abstract][Full Text] [Related]
3. Serological analysis of Helicobacter hepaticus infection in patients with biliary and pancreatic diseases.
Shimoyama T; Takahashi R; Abe D; Mizuki I; Endo T; Fukuda S
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S86-9. PubMed ID: 20586873
[TBL] [Abstract][Full Text] [Related]
4. Increased prevalence of Helicobacter pylori antibodies among nurses.
Wilhoite SL; Ferguson DA; Soike DR; Kalbfleisch JH; Thomas E
Arch Intern Med; 1993 Mar; 153(6):708-12. PubMed ID: 8447708
[TBL] [Abstract][Full Text] [Related]
5. Detection of Helicobacter species in chronic liver disease and chronic inflammatory bowel disease.
Veijola L; Nilsson I; Halme L; Al-Soud WA; Mäkinen J; Ljungh A; Rautelin H
Ann Med; 2007; 39(7):554-60. PubMed ID: 17852032
[TBL] [Abstract][Full Text] [Related]
6. Serum antibodies to Helicobacter hepaticus and Helicobacter pylori in patients with chronic liver disease.
Nilsson I; Lindgren S; Eriksson S; Wadström T
Gut; 2000 Mar; 46(3):410-4. PubMed ID: 10673306
[TBL] [Abstract][Full Text] [Related]
7. Immune responses to bile-tolerant helicobacter species in patients with chronic liver diseases, a randomized population group, and healthy blood donors.
Ananieva O; Nilsson I; Vorobjova T; Uibo R; Wadström T
Clin Diagn Lab Immunol; 2002 Nov; 9(6):1160-4. PubMed ID: 12414744
[TBL] [Abstract][Full Text] [Related]
8. Increased prevalence of seropositivity for non-gastric Helicobacter species in patients with autoimmune liver disease.
Nilsson I; Kornilovs'ka I; Lindgren S; Ljungh Å; Wadström T
J Med Microbiol; 2003 Nov; 52(Pt 11):949-953. PubMed ID: 14532338
[TBL] [Abstract][Full Text] [Related]
9. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and etiological studies of IgG antibodies to Helicobacter pylori detected by enzyme-linked immunosorbent assay].
Misawa K; Kumagai T; Hosogaya S; Yamada K; Okimura S; Shimizu T; Akamatsu T; Tanaka E; Furihata K
Rinsho Byori; 1995 Apr; 43(4):375-80. PubMed ID: 7739120
[TBL] [Abstract][Full Text] [Related]
11. Monitoring sentinel mice for Helicobacter hepaticus, H rodentium, and H bilis infection by use of polymerase chain reaction analysis and serologic testing.
Whary MT; Cline JH; King AE; Hewes KM; Chojnacky D; Salvarrey A; Fox JG
Comp Med; 2000 Aug; 50(4):436-43. PubMed ID: 11020164
[TBL] [Abstract][Full Text] [Related]
12. Risk of infection with Helicobacter pylori and hepatitis A virus in different groups of hospital workers.
Rudi J; Töppe H; Marx N; Zuna I; Theilmann L; Stremmel W; Raedsch R
Am J Gastroenterol; 1997 Feb; 92(2):258-62. PubMed ID: 9040202
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of Helicobacter pylori infection among inhabitants and healthy employees of institutes for the intellectually disabled.
Böhmer CJ; Klinkenberg-Knol EC; Kuipers EJ; Niezen-de Boer MC; Schreuder H; Schuckink-Kool F; Meuwissen SG
Am J Gastroenterol; 1997 Jun; 92(6):1000-4. PubMed ID: 9177519
[TBL] [Abstract][Full Text] [Related]
14. Characterization and application of a new monoclonal antibody with high specificity for Helicobacter hepaticus.
Fukuda Y; Shimoyama T; Ohmura T; Sano Y; Nakabayashi N; Takahashi R; Fujioka T; Mitchell HM; Shimoyama T
Helicobacter; 2009 Feb; 14(1):66-71. PubMed ID: 19191899
[TBL] [Abstract][Full Text] [Related]
15. Presence of antibodies against Helicobacter pylori and its heat-shock protein 60 in the serum of patients with Sjögren's syndrome.
Aragona P; Magazzù G; Macchia G; Bartolone S; Di Pasquale G; Vitali C; Ferreri G
J Rheumatol; 1999 Jun; 26(6):1306-11. PubMed ID: 10381048
[TBL] [Abstract][Full Text] [Related]
16. Detection of Helicobacter species in liver and stomach tissues of patients with chronic liver diseases using polymerase chain reaction-denaturing gradient gel electrophoresis and immunohistochemistry.
Stalke P; Al-Soud WA; Bielawski KP; Bakowska A; Trocha H; Stepinski J; Wadström T
Scand J Gastroenterol; 2005 Sep; 40(9):1032-41. PubMed ID: 16165716
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of Helicobacter pylori infection in patients with hepatitis B.
Fan XG; Zou YY; Wu AH; Li TG; Hu GL; Zhang Z
Br J Biomed Sci; 1998 Sep; 55(3):176-8. PubMed ID: 10367401
[TBL] [Abstract][Full Text] [Related]
18. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases.
Chomvarin C; Ottiwet O; Hahnvajanawong C; Intapan PM; Wongwajana S
Int J Infect Dis; 2009 Sep; 13(5):647-54. PubMed ID: 19233700
[TBL] [Abstract][Full Text] [Related]
19. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics.
Longo-Mbenza B; Nkondi Nsenga J; Vangu Ngoma D
Int J Cardiol; 2007 Oct; 121(3):229-38. PubMed ID: 17368586
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori seroprevalence in patients with chronic bronchitis.
Roussos A; Tsimpoukas F; Anastasakou E; Alepopoulou D; Paizis I; Philippou N
J Gastroenterol; 2002; 37(5):332-5. PubMed ID: 12051531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
